Literature DB >> 10828288

Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis.

R C Goldman1, D Gange.   

Abstract

The continuing spectre of resistance to antimicrobial agents has driven a sustained search for new agents that possess activity on drug resistant bacteria. Although several paths are available to reach this goal, the most generalized would be the discovery and clinical development of an agent that acts on a new target which has not yet experienced selective pressure in the clinical setting. Such a target should be essential to the growth and survival of bacteria, and sufficiently different from, or better still non-existent in, the human host. The transglycosylation reaction that polymerizes biochemical intermediates into peptidoglycan qualifies as such a target. This biochemical system accepts the basic unit N-acetylglucosamine-beta-1, 4-N-acetyl-muramyl-pentapeptide-pyrophosphoryl-undecaprenol (lipid II), and leads to polymerization of the N-acetylglucosamine -beta-1, 4-N-acetyl-muramyl-pentapeptide segment into peptidoglycan. Approaches to targeting this reaction include modification of known glycolipid and glycopeptide natural product antibiotics. The synthesis and antibacterial activity of synthetic analogs of moenomycin having novel antibacterial activities not present in the parent structure will be presented, together with the combinatorial chemistry and assay systems leading to their discovery. Likewise, we will discuss chemical modifications to specific glycopeptide antibiotics that have extended their spectrum to include vancomycin resistant enterococci that substitute D-alanyl-D-lactate for D-alanyl-D-alanine in their peptidoglycan. Two differing theories, one positing the generation of high affinity, specific binding to D-alanyl-D-lactate via glycopeptide dimerization and/or membrane anchoring, and the other supporting direct targeting of the modified glycopeptide to the transglycosylation complex, seek to explain the mechanism of action on vancomycin resistant enterococci. Biochemical evidence in support of these two theories will be discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828288     DOI: 10.2174/0929867003374651

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  25 in total

1.  Functional characterization of penicillin-binding protein 1b from Streptococcus pneumoniae.

Authors:  Anne Marie Di Guilmi; Andréa Dessen; Otto Dideberg; Thierry Vernet
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

2.  Characterization of moenomycin antibiotic complex by multistage MALDI-IT/RTOF-MS and ESI-IT-MS.

Authors:  Martin Zehl; Ernst Pittenauer; Andreas Rizzi; Guenter Allmaier
Journal:  J Am Soc Mass Spectrom       Date:  2006-05-30       Impact factor: 3.109

3.  Degradation and reconstruction of moenomycin A and derivatives: dissecting the function of the isoprenoid chain.

Authors:  Masaatsu Adachi; Yi Zhang; Catherine Leimkuhler; Binyuan Sun; John V LaTour; Daniel E Kahne
Journal:  J Am Chem Soc       Date:  2006-11-01       Impact factor: 15.419

4.  Structural Insights into Inhibition of Escherichia coli Penicillin-binding Protein 1B.

Authors:  Dustin T King; Gregory A Wasney; Michael Nosella; Anita Fong; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2016-11-29       Impact factor: 5.157

5.  Screen for inhibitors of the coupled transglycosylase-transpeptidase of peptidoglycan biosynthesis in Escherichia coli.

Authors:  Vasanthi Ramachandran; B Chandrakala; Vidya P Kumar; Veeraraghavan Usha; Suresh M Solapure; Sunita M de Sousa
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 6.  Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activity.

Authors:  Bohdan Ostash; Suzanne Walker
Journal:  Nat Prod Rep       Date:  2010-08-23       Impact factor: 13.423

7.  Modular synthesis of diphospholipid oligosaccharide fragments of the bacterial cell wall and their use to study the mechanism of moenomycin and other antibiotics.

Authors:  Christian M Gampe; Hirokazu Tsukamoto; Tsung-Shing Andrew Wang; Suzanne Walker; Daniel Kahne
Journal:  Tetrahedron       Date:  2011-12-23       Impact factor: 2.457

8.  The glycosyltransferase domain of penicillin-binding protein 2a from Streptococcus pneumoniae catalyzes the polymerization of murein glycan chains.

Authors:  Anne Marie Di Guilmi; Andréa Dessen; Otto Dideberg; Thierry Vernet
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

9.  Tuning the moenomycin pharmacophore to enable discovery of bacterial cell wall synthesis inhibitors.

Authors:  Christian M Gampe; Hirokazu Tsukamoto; Emma H Doud; Suzanne Walker; Daniel Kahne
Journal:  J Am Chem Soc       Date:  2013-03-04       Impact factor: 15.419

Review 10.  Lipid intermediates in the biosynthesis of bacterial peptidoglycan.

Authors:  Jean van Heijenoort
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.